Home / Market News / $CROX
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

UBS Adjusts Crocs Price Target to $145 From $120, Maintains Neutral Rating

Oct 30, 2026, 10:07 PM UTC · Primary ticker $CROX

UBS has increased its price target for Crocs (CROX) shares from $120 to $145, while reiterating a Neutral rating. This adjustment reflects an updated valuation by the analyst, suggesting a moderately positive outlook on the stock's potential, though not a strong buy signal.

UBS has adjusted its price target for Crocs (CROX) shares upwards from $120 to $145. This change indicates that the analyst sees more upside potential for the stock than previously, likely due to recent financial performance or market trends for the footwear company. However, the maintained 'Neutral' rating suggests that while the valuation has improved, UBS does not see compelling reasons for investors to aggressively buy or sell the stock at current levels. This primarily affects current and potential CROX shareholders, offering a revised perspective on its fair value. In the short term, this could provide a slight positive sentiment boost, but the long-term implications are limited by the neutral rating. A key opportunity for traders might be to observe if other analysts follow suit or if the market reacts positively to the increased price target.

$CROX neutral Price target raised, rating maintained
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.